That's a wrap.
Market opens Friday, Nov 13 at 9:30 AM ET
| Oct 20, 2026 | Sep 30, 2026 | Time not given | $1.32 | Beat$1.34 | +1.01% |
| Jul 16, 2026 | Jun 30, 2026 | Time not given | $1.27 | not recorded | −1.51%2d |
This covers the Jul 16, 2026 report. The Oct 20, 2026 numbers are in the table above.
Ally Financial retreats after Q2 report. investors await clarity on outlook
Ally Financial reported Q2 2026 earnings on July 16. While actual EPS is not available, the stock fell 2.48% the following day on above-average volume, suggesting the market interpreted the report negatively. Consensus estimate was $1.27, but a beat or miss cannot be confirmed. The decline likely reflects concerns over loan loss provisions or a cautious tone from management. The stock remains above its 50-day SMA ($44.04) and trades at a cheap valuation (forward P/E ~7.3x). The next full earnings call is scheduled for July 21, which may provide more detail on margins and outlook.
Better case30%
The initial selloff is overdone. The July 21 earnings call reveals a better-than-feared NIM outlook and stable credit quality, reaffirming Ally's cheap valuation and growth trajectory.
Base case50%
The report confirms a mixed quarter. Valuation remains attractive but near-term headwinds from credit costs and slower loan growth cap upside. The stock trades in a $44-$48 range.
Worse case20%
The earnings report reveals deteriorating credit metrics and a cautious outlook that leads to downward earnings revisions. The stock falls below $44 and tests the 200-day SMA near $42.
Scenario odds are a judgement, not measured.